Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021


HomeMEDTRONIC plcMedtronic Ranked as a Leading Sustainability Company

Medtronic Ranked as a Leading Sustainability Company

November 11, 2020

Medtronic plc today announced that it has been recognized as one of the world’s leading companies for sustainability with its inclusion in the Dow Jones Sustainability North America Index (DJSI North America). The DJSI North America includes a select group of companies based on their performance across a variety of sustainability criteria, including economic performance, environmental stewardship, social responsibility, and corporate governance. This is the 13th consecutive year Medtronic has placed on the prestigious list, considered to be a leading benchmark for corporate sustainability.

“Medtronic has never been more focused on our purpose or clearer on our role as a responsible corporate citizen,” said Medtronic CEO Geoff Martha. “As stewards of human health and well-being, and with an aspiration to be the undisputed leader in healthcare technology, we are committed to prioritizing sustainability to create a better world. We will continue to invest in the environmental, social, and corporate governance (ESG) efforts that are most aligned to our Mission, while also driving long term growth and profitability.”

Medtronic’s sustainability strategy focuses on balancing long-term growth and profitability with creating value by working responsibly in all facets where its business intersects with society. Medtronic’s sustainability performance areas identified as most material to long-term success include, innovation and access to healthcare, product quality and patient safety, inclusion and diversity, ethical business practices, responsible supply management, employee engagement and development, human rights, and environmental stewardship. The company’s sustainability priorities align to various tenets of the Medtronic Mission and frame Medtronic’s contributions to the United Nations Sustainability Goals.

One example of Medtronic’s commitment to ESG factors is its recently announced goal to be carbon neutral in its operations by fiscal year 2030, with an aggressive target to reduce greenhouse gas emissions by 50% by fiscal year 2025 and increasing use of renewable and alternative energy by partnering in virtual power purchase agreements (VPPAs) and investing in renewable energy credits (RECs) and carbon offsets.

Another example is the company’s ongoing focus on inclusion, diversity and equity. The company reported 100% gender pay equity in many countries including the U.S. and 99% gender pay equity for employees globally in fiscal year 2020. In January, the company was one of three recipients of the prestigious 2020 Catalyst Award in recognition of its initiatives for fostering a workplace in which women can advance. Medtronic has also committed to several new actions that will advance its global inclusion, diversity, and equity work for employees and the communities where it operates, including linking inclusion and diversity goals with compensation and advancement opportunities for all people managers in fiscal year 2022.

The DJSI ranking adds to the recognition Medtronic received earlier this year through its continued inclusion in the FTSE4Good Index Series. Companies in the FTSE4Good Index Series have met stringent environmental, social and governance criteria, and are positioned to capitalize on the benefits of responsible business practices. More information can be found at


Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy